These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle. Murphy RM; Verburg E; Lamb GD J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710 [TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoresis laser-induced fluorescence for screening combinatorial peptide libraries in assays of botulinum neurotoxin A. Laing TD; Marenco AJ; Moore DM; Moore GJ; Mah DC; Lee WE J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):240-6. PubMed ID: 16828348 [TBL] [Abstract][Full Text] [Related]
9. Effect of postmortem storage on activity of mu- and m-calpain in five bovine muscles. Camou JP; Marchello JA; Thompson VF; Mares SW; Goll DE J Anim Sci; 2007 Oct; 85(10):2670-81. PubMed ID: 17565059 [TBL] [Abstract][Full Text] [Related]
10. Capillary electrophoretic analysis of cathepsin D action on hemoglobin. Chu Q; O'Dwyer M; Zeece MG J Capillary Electrophor; 1997; 4(3):117-22. PubMed ID: 9484658 [TBL] [Abstract][Full Text] [Related]
11. Differential intracellular distribution and activities of mu- and m-calpains during the differentiation of human myogenic cells in culture. Moraczewski J; Piekarska E; Bonavaud S; Wosinska K; Chazaud B; Barlovatz-Meimon G C R Acad Sci III; 1996 Aug; 319(8):681-6. PubMed ID: 8949391 [TBL] [Abstract][Full Text] [Related]
12. Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Raser KJ; Posner A; Wang KK Arch Biochem Biophys; 1995 May; 319(1):211-6. PubMed ID: 7771786 [TBL] [Abstract][Full Text] [Related]
13. Effect of substrate on Ca2(+)-concentration required for activity of the Ca2(+)-dependent proteinases, mu- and m-calpain. Barrett MJ; Goll DE; Thompson VF Life Sci; 1991; 48(17):1659-69. PubMed ID: 2016996 [TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia. Dargelos E; Poussard S; Brulé C; Daury L; Cottin P Biochimie; 2008 Feb; 90(2):359-68. PubMed ID: 17881114 [TBL] [Abstract][Full Text] [Related]
15. Calpain Zymography: General Methodology and Protocol. Wang KKW Methods Mol Biol; 2017; 1626():279-285. PubMed ID: 28608220 [TBL] [Abstract][Full Text] [Related]
16. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain. Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of mitochondrial calpains. Ozaki T; Tomita H; Tamai M; Ishiguro S J Biochem; 2007 Sep; 142(3):365-76. PubMed ID: 17646173 [TBL] [Abstract][Full Text] [Related]
18. Measuring the activity of farnesyltransferase by capillary electrophoresis with laser-induced fluorescence detection. Berezovski M; Li WP; Poulter CD; Krylov SN Electrophoresis; 2002 Sep; 23(19):3398-403. PubMed ID: 12373769 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of mu-calpain, m-calpain, and calpastatin from postmortem muscle. I. Initial steps. Camou JP; Mares SW; Marchello JA; Vazquez R; Taylor M; Thompson VF; Goll DE J Anim Sci; 2007 Dec; 85(12):3400-14. PubMed ID: 17878283 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin. Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]